Enanta Pharmaceuticals
ENTA
#8068
Rank
S$0.48 B
Marketcap
S$16.57
Share price
0.93%
Change (1 day)
24.52%
Change (1 year)

Earnings for Enanta Pharmaceuticals (ENTA)

Earnings in 2026 (TTM): -S$64.74 Million

According to Enanta Pharmaceuticals 's latest financial reports the company's current earnings are S$65.25 Million. In 2025 the company made an earning of -S$81.8 Million, an increase over its 2024 earnings that were of -S$0.13 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Enanta Pharmaceuticals from 2012 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -S$64.74 Million-20.85%
2025 -S$81.8 Million-34.07%
2024 -S$0.13 Billion-23.87%
2023 -S$0.17 Billion4.39%
2022 -S$0.16 Billion-4.4%
2021 -S$0.17 Billion91.12%
2020 -S$85.45 Million-407.13%
2019 S$27.81 M-78.63%
2018 S$0.13 B117.97%
2017 S$59.73 M-574.65%
2016 -S$12.59 Million-110.83%
2015 S$0.11 B-4.5%
2014 S$0.12 B-638.53%
2013 -S$22.6 Million-137.98%
2012 S$59.49 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
S$33.51 B-52,291.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
S$19.85 B-31,011.08%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
AbbVie
ABBV
S$11.12 B-17,423.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
S$6.45 B-10,144.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
S$9.83 B-15,414.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$15.23 B-23,818.01%๐Ÿ‡บ๐Ÿ‡ธ USA